New study hopes to predict dangerous low blood sugar in type 1 diabetes

NCT ID NCT05616273

Completed Knowledge-focused Sponsor: University of Exeter Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 62 people with type 1 diabetes to see if a test that measures the hormone glucagon can predict the risk of dangerously low blood sugar (hypoglycemia). Participants drank a special liquid meal or received an arginine injection to stimulate glucagon release, and their blood sugar levels were tracked. The goal is to develop a simple blood test that could help doctors identify those at highest risk for hypoglycemia and improve their care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to predict hypoglycemia risk in people with type 1 diabetes, helping doctors tailor care.
What could go wrong: This is a small observational study, not a treatment trial. The findings may not translate into a reliable clinical test or benefit all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia hypoglycemia type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOGLYCEMIA TYPE 1 DIABETES

Contacts and locations

Locations

Royal Devon University Healthcare NHS Foundation Trust

Exeter, Devon, EX2 5DW, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.